vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and BlackSky Technology Inc. (BKSY). Click either name above to swap in a different company.

BlackSky Technology Inc. is the larger business by last-quarter revenue ($35.2M vs $23.1M, roughly 1.5× ADC Therapeutics SA). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 15.9%). Over the past eight quarters, BlackSky Technology Inc.'s revenue compounded faster (20.5% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.

ADCT vs BKSY — Head-to-Head

Bigger by revenue
BKSY
BKSY
1.5× larger
BKSY
$35.2M
$23.1M
ADCT
Growing faster (revenue YoY)
ADCT
ADCT
+20.4% gap
ADCT
36.4%
15.9%
BKSY
Faster 2-yr revenue CAGR
BKSY
BKSY
Annualised
BKSY
20.5%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
BKSY
BKSY
Revenue
$23.1M
$35.2M
Net Profit
$-868.0K
Gross Margin
Operating Margin
-77.7%
-11.8%
Net Margin
-2.5%
Revenue YoY
36.4%
15.9%
Net Profit YoY
95.5%
EPS (diluted)
$0.04
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
BKSY
BKSY
Q4 25
$23.1M
$35.2M
Q3 25
$15.8M
$19.6M
Q2 25
$18.1M
$22.2M
Q1 25
$17.4M
$29.5M
Q4 24
$16.9M
$30.4M
Q3 24
$18.0M
$22.5M
Q2 24
$17.0M
$24.9M
Q1 24
$17.8M
$24.2M
Net Profit
ADCT
ADCT
BKSY
BKSY
Q4 25
$-868.0K
Q3 25
$-41.0M
$-15.3M
Q2 25
$-56.6M
$-41.2M
Q1 25
$-38.6M
$-12.8M
Q4 24
$-19.4M
Q3 24
$-44.0M
$-12.6M
Q2 24
$-36.5M
$-9.4M
Q1 24
$-46.6M
$-15.8M
Operating Margin
ADCT
ADCT
BKSY
BKSY
Q4 25
-77.7%
-11.8%
Q3 25
-196.6%
-85.8%
Q2 25
-244.1%
-62.8%
Q1 25
-163.5%
-40.5%
Q4 24
-191.8%
-20.0%
Q3 24
-197.4%
-58.7%
Q2 24
-170.5%
-47.0%
Q1 24
-188.3%
-54.7%
Net Margin
ADCT
ADCT
BKSY
BKSY
Q4 25
-2.5%
Q3 25
-260.1%
-78.2%
Q2 25
-313.2%
-185.8%
Q1 25
-221.8%
-43.4%
Q4 24
-63.9%
Q3 24
-244.1%
-55.8%
Q2 24
-214.6%
-37.7%
Q1 24
-261.1%
-65.2%
EPS (diluted)
ADCT
ADCT
BKSY
BKSY
Q4 25
$0.04
$0.04
Q3 25
$-0.30
$-0.44
Q2 25
$-0.50
$-1.27
Q1 25
$-0.36
$-0.42
Q4 24
$-0.26
$-0.61
Q3 24
$-0.42
$-0.66
Q2 24
$-0.38
$-0.52
Q1 24
$-0.56
$-0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
BKSY
BKSY
Cash + ST InvestmentsLiquidity on hand
$261.3M
$124.5M
Total DebtLower is stronger
$201.1M
Stockholders' EquityBook value
$-185.8M
$94.9M
Total Assets
$323.1M
$386.2M
Debt / EquityLower = less leverage
2.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
BKSY
BKSY
Q4 25
$261.3M
$124.5M
Q3 25
$234.7M
$146.5M
Q2 25
$264.6M
$93.8M
Q1 25
$194.7M
$75.8M
Q4 24
$250.9M
$52.5M
Q3 24
$274.3M
$63.2M
Q2 24
$300.1M
$41.2M
Q1 24
$234.3M
$35.4M
Total Debt
ADCT
ADCT
BKSY
BKSY
Q4 25
$201.1M
Q3 25
$195.1M
Q2 25
$122.5M
Q1 25
$115.3M
Q4 24
$107.7M
Q3 24
$98.8M
Q2 24
$108.6M
Q1 24
$85.0M
Stockholders' Equity
ADCT
ADCT
BKSY
BKSY
Q4 25
$-185.8M
$94.9M
Q3 25
$-238.2M
$91.1M
Q2 25
$-199.2M
$86.6M
Q1 25
$-238.2M
$88.8M
Q4 24
$-202.6M
$94.0M
Q3 24
$-171.9M
$110.3M
Q2 24
$-131.7M
$76.5M
Q1 24
$-194.4M
$81.7M
Total Assets
ADCT
ADCT
BKSY
BKSY
Q4 25
$323.1M
$386.2M
Q3 25
$289.8M
$380.9M
Q2 25
$321.6M
$310.8M
Q1 25
$272.5M
$284.9M
Q4 24
$322.0M
$254.1M
Q3 24
$349.1M
$245.5M
Q2 24
$371.8M
$224.3M
Q1 24
$308.0M
$210.1M
Debt / Equity
ADCT
ADCT
BKSY
BKSY
Q4 25
2.12×
Q3 25
2.14×
Q2 25
1.41×
Q1 25
1.30×
Q4 24
1.15×
Q3 24
0.90×
Q2 24
1.42×
Q1 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
BKSY
BKSY
Operating Cash FlowLast quarter
$-31.1M
$-9.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
BKSY
BKSY
Q4 25
$-31.1M
$-9.3M
Q3 25
$-29.6M
$-39.0M
Q2 25
$-24.1M
$-7.3M
Q1 25
$-56.3M
$27.2M
Q4 24
$-21.9M
$-1.8M
Q3 24
$-25.0M
$1.0M
Q2 24
$-32.8M
$-1.8M
Q1 24
$-44.1M
$-3.8M
Free Cash Flow
ADCT
ADCT
BKSY
BKSY
Q4 25
Q3 25
Q2 25
Q1 25
$-56.6M
Q4 24
$-21.9M
Q3 24
$-25.3M
Q2 24
$-32.9M
Q1 24
$-44.6M
FCF Margin
ADCT
ADCT
BKSY
BKSY
Q4 25
Q3 25
Q2 25
Q1 25
-325.2%
Q4 24
-129.8%
Q3 24
-140.2%
Q2 24
-193.0%
Q1 24
-250.0%
Capex Intensity
ADCT
ADCT
BKSY
BKSY
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.5%
Q4 24
0.5%
Q3 24
1.2%
Q2 24
0.2%
Q1 24
3.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons